FOR IMMEDIATE RELEASE:
DANVILLE, PA -- If a routine procedure could save your life, wouldn’t you want it done? Colorectal cancer is the second leading cause of cancer deaths, yet it’s highly preventable and detectable.
That’s why Geisinger is joining more than 500 health organizations across the United States by signing the “80% by 2018” pledge.
“80% by 2018,” is a National Colorectal Cancer Roundtable initiative in which hundreds of organizations have already committed to substantially reducing colorectal cancer as a major public health problem for those 50 and older. All are working toward the shared goal of 80% of adults aged 50 and older being regularly screened for colorectal cancer by 2018. By reaching that goal, it is estimated that 277,000 cases and 203,000 colorectal cancer deaths could be prevented by 2030.
Through routine screenings, doctors can find and remove hidden growths, or polyps, in the colon before they become cancerous.
“Colon cancer is a major public health problem,” said Michael Komar, M.D., FACG, Director of Gastroenterology at Geisinger Health System. “Many adults age 50 and older are not getting screened because they don’t believe they are at risk, they don’t understand the various testing options, or such as myself, too busy with work and family responsibilities” Dr. Komar added. “But I owed it to my family to get screened.”
“Colorectal cancer in its early stages usually has no symptoms, and since aging leads to a greater risk, most everyone 50 and older should get screened,” added Dr. Komar.
Despite being highly preventable, detectable and treatable, it is estimated that almost 135,000 cases of colorectal cancer will be diagnosed in 2016.
“We’re thrilled to join the 80% by 2018 initiative to improve colon cancer screening rates for our patients at Geisinger,” said Dr. Komar. “Instead of a public health problem, we can help make colon cancer a public health success story.”
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 10 hospital campuses, a health plan with more than half a million members, a Research Institute and the Geisinger Commonwealth School of Medicine. With nearly 24,000 employees and more than 1,700 employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at Facebook, Instagram, LinkedIn and Twitter.